WalkMe
About Us video
WalkMe is a leading digital adoption platform enhanced by AI, designed to optimize how software supports business growth. It integrates with an organization's tech stack, offering comprehensive visibility into applications and workflows across mobile, web, and desktop environments. The platform identifies inefficiencies, enabling users to build and automate improved workflows, thereby enhancing software and AI tool adoption. WalkMe delivers personalized experiences directly within the work process, supported by clear KPIs for adoption and efficiency, demonstrating the return on investment for software. Aimed at eliminating digital friction, WalkMe supports businesses at any stage of their digital adoption journey, ensuring a smoother transition to optimized digital operations.
WalkMe
Product Walkthrough
WalkMe
Demo video
UI Intelligence focuses on enhancing data entry processes, improving data quality, and providing insights into employee interactions with software tools like Salesforce, thereby streamlining customer and HR case management. It offers a dashboard that presents high-level metrics on user activity, including the number of users, views, form submission errors, and overall time spent in applications, to identify areas for improvement. The dashboard highlights forms with the highest error rates, lowest completion rates, and most time spent, allowing for quick identification of issues for further analysis. Machine learning is utilized to automatically identify all forms used within an application, providing metrics like popularity, completion rate, error rates, and time spent, without requiring any setup, making it easy to prioritize efforts to enhance the employee experience. UI Intelligence employs AI-based algorithms to analyze user interactions with software interfaces, offering insights and solutions for improving data integrity and efficiency. The technology works out of the box, requiring no configuration, and supports additional platforms like ServiceNow and SAP SuccessFactors, with a 68-day trial available.